A Study to Assess the Safety, Tolerability and Efficacy of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-048)
Clinical trial NCT00379951 · COMPLETED
Trial details
- NCT number
- NCT00379951
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2006-05-01
- Enrollment
- 107
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.